


Sun Pharma Announces Top-Line Results from the Phase 2 Clinical Trials Evaluating SCD-044 for Moderate to Severe Psoriasis and Atopic Dermatitis
Read More
Press Release Completion of Checkpoint Acquisition
Read More
Sun Pharma reports Q4 and full year results for FY25
Read More
Recent Comments